Group 1 - Centene Corporation (NYSE:CNC) is identified as a low PE ratio stock within the S&P 500, with a current PE ratio of 8.03x [1][3] - Cantor Fitzgerald has assigned a Neutral rating to Centene, setting a price target of $38, citing that finalized rates are generally close to payor proposals but fall short of the desired 30%+ increases for 2026 [1][2] - The analysis of finalized rates in the first 15 states shows that Centene's rates were approximately 30 basis points higher than initial proposals, with notable discrepancies in states like New York, where an 8.1% proposed increase was finalized at only 2.9% [2][3] Group 2 - The market environment for Centene remains uncertain due to political factors, particularly concerning the CMS Marketplace Integrity & Affordability Final Rule and the potential expiration of premium-enhanced subsidies at the end of the year [3] - Centene operates in the Healthcare Providers & Services industry, focusing on providing services to under-insured and uninsured individuals, as well as commercial organizations in the United States [3]